# ARCL Organics (NSE: ARCL) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/ARCL · Pivot · prices to 22 Oct 2026

ARCL Organics (NSE: ARCL) closed at ₹224.00 on 22 Oct 2026, up 2.75% on the day. With a market capitalisation of ₹179 Cr, it ranks 2336th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Cement & Materials sector; its industry is Specialty Chemicals.

At its last close the stock traded at 34.6× trailing earnings, against a return on equity of 6.3% in FY26. Its 52-week range is ₹211.50 (8 Oct 2026) to ₹280.70 (17 Sep 2026); the last close is 20.2% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹65 Cr (−9.6% year on year) and net profit ₹3 Cr (−50.2%), on a consolidated basis. Promoters held 69.22% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹224.00 |
| Market cap | ₹179 Cr |
| P/E (trailing) | 34.6 |
| ROE | 6.3% (FY26) |
| ROCE | 18.5% (FY26) |
| Debt to equity | 0.86 |
| 52-week high | ₹280.70 (17 Sep 2026) |
| 52-week low | ₹211.50 (8 Oct 2026) |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹65 Cr | −9.6% | ₹3 Cr | −50.2% | ₹3.49 |
| Q3 FY26 | ₹53 Cr | −13.7% | −₹9 Cr | −592.2% | −₹11.01 |
| Q2 FY26 | ₹86 Cr | +52.7% | ₹7 Cr | +231.2% | ₹8.90 |
| Q1 FY26 | ₹67 Cr | +12.4% | ₹4 Cr | +44.0% | ₹4.99 |
| Q4 FY25 | ₹72 Cr | +25.5% | ₹6 Cr | +11.1% | ₹7.00 |
| Q3 FY25 | ₹62 Cr | +28.2% | ₹2 Cr | −52.9% | ₹2.24 |
| Q2 FY25 | ₹56 Cr | +30.5% | ₹2 Cr | +74.4% | ₹2.72 |
| Q1 FY25 | ₹60 Cr | +44.1% | ₹3 Cr | +41.3% | ₹3.46 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹251 Cr | ₹12 Cr |
| FY24 | ₹191 Cr | ₹11 Cr |
| FY23 | ₹165 Cr | ₹12 Cr |
| FY22 | ₹141 Cr | ₹11 Cr |
| FY21 | ₹87 Cr | ₹8 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 69.22%
- Domestic institutions: 0.75%
- Non-institutions: 30.03%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Tainwala Chem](https://app.pivotnow.in/stock/TAINWALCHM) | ₹200.00 | ₹187 Cr | 17.4 | — |
| [Emergent Ind](https://app.pivotnow.in/stock/EMERGENT) | — | ₹187 Cr | — | — |
| [Mahalaxmi Rubtech](https://app.pivotnow.in/stock/MHLXMIRU) | ₹167.00 | ₹177 Cr | 8.1 | — |
| [South (I) Paper](https://app.pivotnow.in/stock/SIPAPER) | — | ₹176 Cr | — | — |
| [Emmbi Industries](https://app.pivotnow.in/stock/EMMBI) | ₹88.87 | ₹171 Cr | 21.7 | — |
| [Stratmont Indus](https://app.pivotnow.in/stock/STRATMONT) | — | ₹170 Cr | — | — |

## Questions and answers

### What is the share price of ARCL Organics today?

ARCL Organics (NSE: ARCL) last closed at ₹224.00 on 22 Oct 2026. Its 52-week high is ₹280.70 and its 52-week low is ₹211.50.

### What is the market cap of ARCL Organics?

ARCL Organics' market capitalisation is ₹179 Cr (₹179 Cr) at the 22 Oct 2026 close, ranking 2336th among the NSE companies Pivot tracks.

### What is the P/E ratio of ARCL Organics?

ARCL Organics trades at a trailing P/E of 34.6. The median P/E of the 3 closest Cement & Materials peers by market cap is 17.4.

### What is the ROE and ROCE of ARCL Organics?

Return on equity was 6.3% in FY26 and return on capital employed was 18.5% in FY26 (consolidated figures).

### Is ARCL Organics a debt-free company?

No. ARCL Organics' debt-to-equity ratio was 0.86 in FY26, with total debt of ₹28 Cr.

### What were ARCL Organics' latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), ARCL Organics reported revenue of ₹65 Cr, −9.6% year on year, and net profit of ₹3 Cr, −50.2% year on year.

### What is the shareholding pattern of ARCL Organics?

As of 30 Jun 2026: promoters 69.22%, domestic institutions 0.75%, non-institutions 30.03%.

### Who are ARCL Organics' competitors?

The listed Cement & Materials companies closest to ARCL Organics by market cap are Tainwala Chem, Emergent Ind, Mahalaxmi Rubtech, South (I) Paper, Emmbi Industries and Stratmont Indus.

### Is ARCL Organics a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out ARCL Organics' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ARCL against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.